Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

Clinical trial NCT00907296 · COMPLETED

Trial details

NCT number: NCT00907296
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fracture Healing

Start date: 2009-09-02
Primary completion: 2012-03-06
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.